Ozempic Face: What Causes It and Can You Prevent It?

You've probably seen the phrase in headlines, on social media, maybe even heard it at a dinner party. Someone mentions they're considering a GLP-1 medication and a well-meaning friend says: "But what about ozempic face?"

It's become one of those terms that carries more anxiety than information. And if you're already taking semaglutide, tirzepatide or another weight loss medication — or thinking about starting — the idea that your face might age overnight is understandably unsettling. So let's look at what's actually going on, what the clinical evidence says, and what you can do about it.

What is ozempic face?

Let's be clear about something first: "ozempic face" isn't a medical diagnosis. You won't find it in any clinical textbook. It's a colloquial term that describes the facial changes some people notice after losing a significant amount of weight on GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro).

What people are actually describing is facial volume loss. When you lose body fat, you lose it everywhere, including the fat pads that sit beneath the skin of your face. These fat pads are what give your face its structure and fullness. When they shrink, the skin that was stretched over them can appear loose, hollow or saggy. The cheeks look flatter. The under-eye area can appear more sunken. Fine lines and wrinkles become more visible.

The result can make someone look noticeably older, even if they feel healthier and more energetic than they have in years.

Why does it happen?

This is where a lot of the media coverage gets it wrong. Ozempic face isn't caused by semaglutide itself. There's no evidence that GLP-1 medications directly affect skin elasticity, collagen production or facial fat distribution in any unique way.

What GLP-1 medications do is suppress appetite very effectively. People eat less. They lose weight, often quite rapidly, particularly in the first few months. And rapid weight loss is the key factor here.

Think of it this way. Your facial skin has spent years accommodating the volume beneath it. When that volume reduces quickly, the skin doesn't snap back immediately. It can't. Skin elasticity is determined by collagen and elastin fibres, and these degrade naturally with age. The older you are when you lose weight, the less likely your skin is to keep up with the change in volume underneath.

This is why the same phenomenon occurs after gastric sleeve surgery, gastric bypass, or even prolonged calorie restriction diets. A study in the journal Obesity Surgery found comparable rates of facial volume loss in patients who lost equivalent amounts of weight through surgical and non-surgical means. The weight loss method didn't matter. The speed and amount of loss did.

Signs of ozempic face

Facial volume loss doesn't happen overnight, and it doesn't look the same for everyone. But the patterns tend to be consistent:

Hollowing around the cheeks. The buccal fat pads — the small pockets of fat that give your mid-face its roundness — are often the first to visibly reduce. This can create a gaunt or drawn appearance, particularly under certain lighting.

Deepening of the nasolabial folds. Those lines that run from the sides of your nose to the corners of your mouth become more pronounced when the surrounding fat diminishes.

Under-eye hollowing. The tear trough area can look more sunken, creating shadowing that wasn't there before.

Increased visibility of fine lines and wrinkles. Particularly across the forehead and around the mouth. When the skin loses the padding beneath it, surface texture changes become more apparent.

A general "deflated" appearance. Some patients describe looking tired or unwell, even though they physically feel much better.

Not everyone experiences all of these. Some notice very little change at all. But when several happen together, the visual impact can be striking.

Who is most at risk?

Several factors influence how much facial volume loss you're likely to experience:

Age. This is the single biggest predictor. Skin elasticity declines from your mid-30s onwards, with a more noticeable drop after 50. A 28-year-old losing 15kg on Wegovy will almost certainly see less facial change than a 55-year-old losing the same amount.

Speed of weight loss. Losing 1-2 lbs per week gives your skin more time to adjust. Losing 4-5 lbs per week — which can happen in the early weeks of GLP-1 treatment — doesn't. The faster the loss, the more pronounced the mismatch between skin surface area and the volume beneath it.

Total amount of weight lost. Someone who loses 8-10% of their body weight will generally see less facial change than someone who loses 20%+. Since clinical trials for semaglutide show average losses of 15-17% and tirzepatide up to 22%, significant facial change is a realistic possibility for many patients.

Genetics and skin type. Some people naturally have thicker skin with more collagen. Others have thinner, more translucent skin that shows volume changes more readily. Sun damage also plays a role — years of UV exposure breaks down collagen and elastin, leaving less structural reserve.

Smoking history. Smokers and former smokers tend to have reduced collagen density, which means their skin is less equipped to adapt to volume changes.

Starting body composition. People who carry more of their weight in their face — which is partly genetic — may notice more dramatic changes.

How to reduce the risk of ozempic face

You can't entirely eliminate the possibility of facial volume loss if you're losing a significant amount of weight. But you can meaningfully influence how pronounced it is.

Slow your rate of loss where possible

This is the most impactful thing you can do. GLP-1 medications are typically prescribed using a dose titration schedule — you start on a lower dose and increase gradually. This isn't just about managing side effects like nausea. It also means the weight loss tends to be more gradual in the early weeks, which is better for skin adaptation.

If you're losing weight very rapidly (more than 1kg per week consistently), it's worth discussing your titration schedule with your prescriber. Sometimes staying on a lower dose for an extra few weeks can moderate the pace of loss without significantly affecting long-term outcomes.

Prioritise protein

Protein intake matters more than most people realise during weight loss. When you're eating less overall, there's a risk of losing muscle mass alongside fat, and facial muscles contribute to facial structure. Aim for at least 1.2-1.6g of protein per kilogram of body weight daily. Good sources include lean meat, fish, eggs, Greek yoghurt, legumes and tofu.

A 2023 study published in The New England Journal of Medicine found that patients on semaglutide who maintained higher protein intake preserved significantly more lean mass than those who didn't. While the study focused on whole-body composition rather than facial appearance specifically, the principle holds.

Stay hydrated

Dehydration makes skin look thinner and less plump. It's simple, but adequate water intake — around 2 litres daily for most adults — supports skin turgor and can soften the visual impact of volume loss. Some patients find that increasing their water intake is one of the first things that visibly helps.

Protect your skin from sun damage

UV radiation is the single largest external contributor to collagen breakdown. If you're losing weight and want to preserve as much skin elasticity as possible, daily SPF 30+ is a great option. This applies year-round in the UK, not just in summer.

Consider a targeted skincare routine

Retinoids (vitamin A derivatives) are the most evidence-backed topical option for stimulating collagen production. Prescription-strength tretinoin is the gold standard, but over-the-counter retinol can also help with consistent use over several months. Vitamin C serums and peptide-based moisturisers offer additional collagen support.

Resistance training

Strength training helps preserve and build lean muscle mass throughout your body, including the muscles that support facial structure. It also improves overall body composition, which can reduce the total amount of fat you need to lose to reach a healthy weight.

Is ozempic face reversible?

This is probably the question that causes the most worry. The honest answer: it depends.

Partial reversal is common. Once your weight stabilises — which typically happens after 12-18 months on GLP-1 medication — your skin does continue to gradually adapt. Collagen remodelling is a slow process, but it happens. Many patients find that the gaunt appearance softens over 6-12 months of weight maintenance, even without any additional interventions.

Age matters here too. Younger patients tend to see more natural recovery. Their skin retains more elasticity and collagen-producing capacity. For patients over 50, the recovery is often less complete.

Cosmetic options exist. Dermal fillers — particularly hyaluronic acid fillers — can restore lost volume in the cheeks, tear troughs and nasolabial folds. These are temporary (lasting 6-18 months depending on the product) but can be very effective. Some dermatologists also offer collagen-stimulating treatments like Sculptra (poly-L-lactic acid), which works more gradually but can produce longer-lasting results.

These are personal decisions that sit outside the medical treatment of obesity. But they're worth knowing about if facial changes are affecting your confidence or quality of life.

Does every GLP-1 medication cause this?

Ozempic gets the name recognition because it was the first GLP-1 agonist to become widely known in popular culture. But the facial changes associated with rapid weight loss aren't specific to semaglutide.

Patients on Wegovy (the higher-dose version of semaglutide licensed specifically for weight management) can experience the same thing, often to a greater degree because the weight loss tends to be more substantial.

Mounjaro (tirzepatide), which targets both GLP-1 and GIP receptors, produces even greater average weight loss — up to 22.5% of body weight in the SURMOUNT-1 trial. With more weight lost, the potential for facial volume change increases proportionally.

The newer medications in development — oral semaglutide at higher doses, survodutide, retatrutide — are expected to produce similar or greater weight loss. "Ozempic face" as a concept will likely need a new name before long.

The point is this: it's a weight loss phenomenon, not a medication side effect in the traditional sense. Any treatment that helps you lose a significant amount of weight, whether pharmaceutical, surgical or dietary, carries the same possibility.

Does everyone get ozempic face?

No.

Clinical trials of semaglutide and tirzepatide don't specifically track facial volume loss as an outcome, so we don't have precise incidence figures. But based on what dermatologists and weight management clinicians report, a meaningful proportion of patients who lose 15%+ of their body weight will notice some degree of facial change.

However, "some degree" covers a wide spectrum. For many people, it's subtle — perhaps a slight hollowing of the cheeks that only they notice. For others, particularly those over 50 who lose weight rapidly, it can be more marked.

Some people experience no noticeable facial changes at all. Body fat distribution is highly individual. If you tend to carry very little fat in your face to begin with, there's simply less to lose.

Takeaways

Ozempic face is a real phenomenon, but it's not unique to Ozempic and it's not inevitable. It's what happens when significant weight is lost quickly and the skin — particularly in the face — can't keep pace. Slowing your rate of loss, eating enough protein and protecting your skin gives your body the best chance to adapt. And if facial changes do occur, they often soften over time as your weight stabilises.

If you're considering starting a GLP-1 medication and this is a concern, raise it with your prescriber. It's a perfectly reasonable thing to factor into your treatment plan. A good clinician will help you find a pace of weight loss that balances health outcomes with how you feel about the changes along the way.

Frequently asked questions

What exactly is ozempic face?

Ozempic face is a colloquial term for the facial volume loss — sagging skin, hollow cheeks, deeper wrinkles — that can occur after significant weight loss on GLP-1 medications like semaglutide or tirzepatide. It's caused by the loss of facial fat pads, not by the medication itself. The same changes can occur with any form of rapid weight loss.

How long does it take for ozempic face to appear?

Most people who notice facial changes report them becoming visible after losing 10-15% of their body weight, which typically happens within the first 4-6 months of treatment. However, this varies considerably depending on age, starting weight and rate of loss.

Can you reverse ozempic face naturally?

Partially, yes. Once your weight stabilises, your skin continues to remodel and adapt over the following 6-12 months. Good skincare (particularly retinoids and SPF), adequate hydration and protein intake support this process. For more significant volume loss, cosmetic treatments like dermal fillers can restore facial fullness.

Is ozempic face permanent?

Not necessarily. Mild to moderate facial volume loss often improves naturally over time as weight stabilises and skin gradually adapts. More significant changes, particularly in older patients, may not fully resolve without cosmetic intervention. The degree of permanence depends largely on age, skin quality and how much volume was lost.

Does Mounjaro cause ozempic face too?

Yes. Since Mounjaro (tirzepatide) typically produces even greater weight loss than semaglutide — up to 22.5% of body weight in clinical trials — the potential for facial volume loss is at least comparable. Any medication or intervention that produces significant weight loss carries the same possibility.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any treatment.